0      0

2021 NPPA

13 - Sponsored Product Theater: CDPATH™ a Personalized Prognostic Tool for Crohn’s disease


Aug 14, 2021 6:00pm ‐ Aug 14, 2021 7:00pm


Description

Dr. Siegel discusses CDPATH, which uses a blood test to evaluate an adult patient’s potential risk within 3 years of developing bowel strictures, internal penetrating disease, or non-perianal surgery (bowel resection or stricturoplasty). Used with physician’s assessment, CDPATH can help facilitate shared decision-making (U.S. availability; no cost to eligible patients).

This Product Theater is sponsored by Takeda and is not affiliated with AGA.

Speaker(s):

You must be logged in and own this session in order to post comments.